Trade Names:
Status: Approved
Entry Type: Combination
Molecule Category: Mixture
Compounds in the Mixture: RITUXIMAB HYALURONIDASE (HUMAN RECOMBINANT)

Related Entries

Parent
Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
19.42
Skin and subcutaneous tissue disorders
12.5
Injury, poisoning and procedural complications
12.12
Gastrointestinal disorders
8.46
Nervous system disorders
6.73
Infections and infestations
6.35
Vascular disorders
5.58
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
4.81
Musculoskeletal and connective tissue disorders
4.04
Blood and lymphatic system disorders
3.85
Respiratory, thoracic and mediastinal disorders
3.46
Immune system disorders
3.08
Cardiac disorders
2.5